ZA936613B - Pharmaceuticals - Google Patents
PharmaceuticalsInfo
- Publication number
- ZA936613B ZA936613B ZA936613A ZA936613A ZA936613B ZA 936613 B ZA936613 B ZA 936613B ZA 936613 A ZA936613 A ZA 936613A ZA 936613 A ZA936613 A ZA 936613A ZA 936613 B ZA936613 B ZA 936613B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceuticals
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929219163A GB9219163D0 (en) | 1992-09-10 | 1992-09-10 | Pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA936613B true ZA936613B (en) | 1994-05-16 |
Family
ID=10721705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA936613A ZA936613B (en) | 1992-09-10 | 1993-09-08 | Pharmaceuticals |
Country Status (13)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5998409A (en) * | 1992-03-12 | 1999-12-07 | Smithkline Beecham Plc | Condensed indole derivatives as 5HT4 -receptor antagonists |
| US5852014A (en) * | 1992-03-12 | 1998-12-22 | Smithkline Beecham P.L.C. | Condensed indole derivatives as 5HT4 -receptor antagonists |
| JPH08502273A (ja) * | 1992-10-13 | 1996-03-12 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５−ｈｔ▲下４▼レセプターアンタゴニスト用複素環式エステルまたはアミド |
| WO1994008965A1 (en) * | 1992-10-16 | 1994-04-28 | Smithkline Beecham Plc | N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists |
| GB9312348D0 (en) * | 1993-06-16 | 1993-07-28 | Smithkline Beecham Plc | Pharmaceuticals |
| WO1997017345A1 (fr) * | 1995-11-09 | 1997-05-15 | Synthelabo | Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one, utiles comme ligands des recepteurs 5-ht4 ou h¿3? |
| FR2741070B1 (fr) * | 1995-11-09 | 1997-12-12 | Synthelabo | Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique |
| TW445263B (en) | 1996-02-29 | 2001-07-11 | Janssen Pharmaceutica Nv | Novel esters of 1,4-disubstituted piperidine derivatives |
| CN1142161C (zh) * | 1998-09-10 | 2004-03-17 | 弗·哈夫曼-拉罗切有限公司 | 作为5－ht4受体拮抗剂的二氢苯并二噁烯羧酰胺与酮衍生物 |
| TW570920B (en) | 1998-12-22 | 2004-01-11 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
| GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
| EP1641783B1 (en) | 2003-06-19 | 2012-03-28 | Janssen Pharmaceutica NV | Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| CN103420989B (zh) * | 2012-05-15 | 2016-03-23 | 华中科技大学 | 苯并二噁烷类衍生物及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4186135A (en) * | 1976-08-04 | 1980-01-29 | Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France | Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation |
| US4268512A (en) * | 1976-08-04 | 1981-05-19 | Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France | Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation |
| SE8503055D0 (sv) * | 1985-06-19 | 1985-06-19 | Astra Laekemedel Ab | Piperonylcarboxamido derivatives |
| US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| DE69026759D1 (de) * | 1989-07-03 | 1996-06-05 | Yoshitomi Pharmaceutical | Benzazin-Verbindungen und deren pharmazeutische Verwendungen |
| GB9005014D0 (en) * | 1990-03-06 | 1990-05-02 | Janssen Pharmaceutica Nv | N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives |
| GB9027098D0 (en) * | 1990-12-13 | 1991-02-06 | Beecham Group Plc | Pharmaceuticals |
| ES2135414T3 (es) * | 1991-09-12 | 1999-11-01 | Smithkline Beecham Plc | Antagonistas del receptor 5-ht4. |
| JPH05194406A (ja) * | 1991-11-12 | 1993-08-03 | Yoshitomi Pharmaceut Ind Ltd | 新規アミド化合物 |
| NZ246915A (en) * | 1992-02-06 | 1996-05-28 | Smithkline Beecham Plc | Benzopyran, benzothiopyran and benzofuran derivatives, preparation and pharmaceutical compositions thereof |
-
1992
- 1992-09-10 GB GB929219163A patent/GB9219163D0/en active Pending
-
1993
- 1993-09-07 JP JP6507019A patent/JPH08501293A/ja active Pending
- 1993-09-07 CA CA002144423A patent/CA2144423A1/en not_active Abandoned
- 1993-09-07 NZ NZ255535A patent/NZ255535A/en unknown
- 1993-09-07 US US08/397,229 patent/US5620992A/en not_active Expired - Fee Related
- 1993-09-07 EP EP94908824A patent/EP0659183A1/en not_active Withdrawn
- 1993-09-07 WO PCT/GB1993/001895 patent/WO1994005654A1/en not_active Application Discontinuation
- 1993-09-07 AU AU49764/93A patent/AU682317B2/en not_active Ceased
- 1993-09-07 KR KR1019950700940A patent/KR950703557A/ko not_active Ceased
- 1993-09-08 MX MX9305510A patent/MX9305510A/es unknown
- 1993-09-08 ZA ZA936613A patent/ZA936613B/xx unknown
- 1993-09-09 CN CN93117670A patent/CN1040645C/zh not_active Expired - Fee Related
- 1993-09-13 TW TW082107482A patent/TW268006B/zh active
-
1996
- 1996-12-20 US US08/771,093 patent/US5786372A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08501293A (ja) | 1996-02-13 |
| CN1040645C (zh) | 1998-11-11 |
| CN1089946A (zh) | 1994-07-27 |
| GB9219163D0 (en) | 1992-10-28 |
| US5786372A (en) | 1998-07-28 |
| AU682317B2 (en) | 1997-10-02 |
| AU4976493A (en) | 1994-03-29 |
| CA2144423A1 (en) | 1994-03-17 |
| MX9305510A (es) | 1994-05-31 |
| NZ255535A (en) | 1996-10-28 |
| KR950703557A (ko) | 1995-09-20 |
| EP0659183A1 (en) | 1995-06-28 |
| WO1994005654A1 (en) | 1994-03-17 |
| TW268006B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1996-01-11 |
| US5620992A (en) | 1997-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9300494A0 (en) | Pharmaceuticals | |
| GB9221468D0 (en) | Pharmaceuticals | |
| GB9204565D0 (en) | Pharmaceuticals | |
| GB9205917D0 (en) | Pharmaceuticals | |
| GB9219163D0 (en) | Pharmaceuticals | |
| GB9214184D0 (en) | Pharmaceuticals | |
| GB9201961D0 (en) | Pharmaceuticals | |
| GB9220585D0 (en) | Pharmaceuticals | |
| GB9208321D0 (en) | Pharmaceuticals | |
| GB9215499D0 (en) | Pharmaceuticals | |
| GB9211926D0 (en) | Pharmaceuticals | |
| GB9221442D0 (en) | Pharmaceuticals | |
| GB9220699D0 (en) | Pharmaceuticals | |
| GB9221443D0 (en) | Pharmaceuticals | |
| GB9221445D0 (en) | Pharmaceuticals | |
| GB9220508D0 (en) | Pharmaceuticals | |
| GB9205427D0 (en) | Pharmaceuticals | |
| GB9219356D0 (en) | Pharmaceuticals | |
| GB9219355D0 (en) | Pharmaceuticals | |
| GB9219354D0 (en) | Pharmaceuticals | |
| GB9205365D0 (en) | Pharmaceuticals | |
| GB9218846D0 (en) | Pharmaceuticals | |
| GB9216906D0 (en) | Pharmaceuticals | |
| GB9211072D0 (en) | Pharmaceuticals | |
| GB9214399D0 (en) | Pharmaceuticals |